This site uses cookies. By continuing to use this site you agree to our use of cookies. To find out more, see our Privacy and Cookies policy.
Skip to the content

IOP A community website from IOP Publishing

Product details

Varian receives FDA 510(k) clearance for its ProBeam proton therapy system Jan 20, 2014

Varian Medical Systems (VAR: Quote) said it has received FDA 510(k) clearance for its updated ProBeam proton therapy system.

The company noted that its ProBeam system gives clinicians options for delivering dose precisely in order to minimize dose to healthy tissue in the course of delivering proton therapy treatments for cancer. Its scanning beam technology enables intensity-modulated proton therapy or IMPT by modulating dose levels on a spot-by-spot basis throughout the treatment area.

The company noted that Irradiations from multiple angles are combined in an optimal manner to improve control of dose distributions. Scanning beam technology also eliminates the time-consuming need to manually insert separate shaping accessories for each beam angle in order to match the beam to the shape of the tumor.


More products from this company